Drug Patent Watch

DECEMBER 18, 2024

Consider using a variety of claim types, including: Compound claims Method of treatment claims Formulation claims Dosage regimen claims Each type of claim offers different protections and can be valuable in different scenarios. Balancing Profit and Public Health Pharmaceutical companies face increasing scrutiny over drug pricing and access.

Drug Development 96

Drug Development Compounding Dosage Pharmaceutical Companies 96

Pharmacy Times

JUNE 23, 2025

This pathway’s expanded use and shifting Centers for Medicare & Medicaid Services (CMS) policies are reshaping reimbursement practices and therapeutic equivalence standards for 505(b)(2) drugs. Based on this ruling, 505(b)(2) drugs that are not therapeutically interchangeable should be considered sole-source drugs.

Pharmacy Technician 26

Pharmacy Technician Compounding Pharmacies Dosage Hospitals 26

Pharmaceutical Commerce

JUNE 9, 2025

As of now, supply for this coming season matches last year’s total dosage, with production expected to continue. Expanded manufacturing capacity for the upcoming season Now, the Sanofi-AstraZeneca partnership has resulted in tripled production capacity, along with twice the number of manufacturing facilities.

Drug Pricing 52

Drug Pricing Vaccines Immunity Immunization 52

Viseven

JANUARY 13, 2023

Evaluation of drug efficiency on a dedicated market is a complex process that requires HEOR experts to measure multiple indicators to understand the actual market value of the product. So what do exactly HEOR experts do for the pharmaceutical companies and what HEOR-collected data is used for? What is HEOR Data?

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Dosage Pharmaceutical Manufacturing 40

European Pharmaceutical Review

OCTOBER 19, 2022

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment.

Biosimilars 96

Biosimilars Dosage Drug Pricing Pharmaceutical Companies 96

Pharmaceutical Technology

SEPTEMBER 26, 2022

Sandoz has a strong global brand and a unique heritage in areas ranging from generic antibiotics to biosimilars; it is also determined to differentiate itself as the off-patent company with the greatest focus on identifying and meeting patient needs.”. The company had revenues of $9.6bn both in 2020 and last year.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

Drug Patent Watch

DECEMBER 19, 2024

As companies invest billions in research and development, protecting their innovations through strategic patent management has become more important than ever. This comprehensive guide will explore how pharmaceutical companies can leverage their drug patent portfolios to maximize value, maintain market dominance, and drive innovation.

Pharmaceutical Companies 81

Pharmaceutical Companies Pharmaceutical Companies Dosage Drug Pricing 81